Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Mangalam Drugs & Organics

BSE: 532637|NSE: MANGALAM|ISIN: INE584F01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Oct 18, 15:51
145.45
-1.2 (-0.82%)
VOLUME 8,608
LIVE
NSE
Oct 18, 15:52
145.85
-1.25 (-0.85%)
VOLUME 38,002
Announcements on Mangalam Drugs

18th-Oct-2017 12:02Source: BSE

Mangalam Drugs & Organics- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Kishoriju Trading & Investment Pvt Ltd

16th-Oct-2017 15:21Source: BSE

Mangalam Drugs & Organics- Certificate Under Regulation 40 (10) Of SEBI (LODR) Regulations 2015 For Half Year Ended 30Th September, 2017.

Please find enclosed herewith the Certificate Under Regulation 40(9) / 40(10) of Securities and Exchange Board of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 for the half...

13th-Oct-2017 16:46Source: BSE

Mangalam Drugs & Organics- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt...

13th-Oct-2017 12:47Source: BSE

Mangalam Drugs & Organics- Statement Of Investor Complaints For Quarter Ended 30Th September, 2017

Pursuant to the provisions of Regulation 13(3) (Listing Obligation and Disclosure Requirement) Regulations, 2015, enclosed herewith is the Investor Grievance Report of our company for the Quarter ende...

13th-Oct-2017 10:50Source: BSE

Mangalam Drugs & Organics- Shareholding for the Period Ended September 30, 2017

Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

12th-Oct-2017 08:24Source: BSE

Mangalam Drugs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt Ltd

10th-Oct-2017 12:29Source: BSE

Mangalam Drugs- Compliance Certificate For The Period Ended 30Th September, 2017

With reference to the subject matter, please find enclosed herewith the Compliance Certificate under Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, duly ...

4th-Oct-2017 13:58Source: BSE

Mangalam Drugs- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment...

30th-Sep-2017 08:21Source: BSE

Mangalam Drugs- Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has now received the revised disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment...

30th-Sep-2017 08:21Source: BSE

Mangalam Drugs- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt Ltd

1 2 3 4 5 Next >>
Quick Links for Mangalam Drugs & Organics
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.